Search results

19 results found.

Notice of alternative medication authorization, December 1, 2022
/en/media/14226
This notice was published on December 7, 2022.

Minoxidil replaces Loniten.
Application for Review
/en/media/2841
Do you disagree with any other decision rendered by RAMQ? You have 6 months to contest the decision by filing an application for review.

Form 4185
Notice of alternative medication authorization, July 6, 2020
/en/media/9151
This notice was published on October 20, 2020.

Timolol maleate replaces:
- Apo-Timop
- Jamp-Timolol
- pms-Timolol
- Sandoz Timolol
- Timoptic
Notice of alternative medication authorization, January 20, 2020
/en/media/9156
This notice was published on October 20, 2020.

Timolol maleate replaces:
- Apo-Timop
- Jamp-Timolol
- pms-Timolol
- Sandoz Timolol
- Timoptic
Notice of alternative medication authorization, January 20, 2020
/en/media/9161
This notice was published on October 20, 2020.

Timolol maleate replaces:
- Apo-Timop
- Jamp-Timolol
- pms-Timolol
- Sandoz Timolol
- Timoptic
Sworn Statement – Proof of Residence
/en/media/2876
Form used to confirm the place of residence of a person or family. Must be signed before a commissioner for oaths. The form remains valid for 45 days.

Form 4249
Information distribution
/en/about-us/information-distribution
RAMQ publishes information and documents in keeping with the Regulation respecting the distribution of information and the protection of personal information.
Privacy policy
/en/about-us/privacy-policy
RAMQ applies rigorous security and privacy measures on its website in order to safeguard users’ personal information and privacy.
Report wrongdoing (a person or situation)
/en/contact-us/report-wrongdoing-a-person-situation
You can report wrongdoing on the part of citizens, health professionals, organizations or report any situation in contravention of the agreements, statutes and regulations of the RAMQ.

Search results

How did we do?